Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 10/9/2025

Long-Acting Injectable Antipsychotics

Introduction to LAI Antipsychotics

  • The currently available LAI antipsychotics include both first-generation agents and second-generation agents, with second-generation LAIs being preferred due to better tolerability and fewer neurological side effects, as recommended by the American College of Psychiatry 1

First-Generation LAI Antipsychotics

  • Fluphenazine decanoate is available as a first-generation depot formulation, according to the British Journal of Psychiatry guidelines 2

Second-Generation LAI Antipsychotics

  • No cited facts are available for second-generation LAI antipsychotics that meet the inclusion criteria.

REFERENCES

1

Long-Acting Injectable Antipsychotics: Clinical Positioning and Recommendations [LINK]

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025